US FDA Posts Agent In Singapore But Other Foreign Offices Close
This article was originally published in PharmAsia News
Executive Summary
The US FDA is consolidating its China offices to allow the regulatory agency to 'strategically focus its resources' but has placed a new agent in Singapore as part of its crime-fighting effort.